{"id":"W1994649501","doi":"10.1002/art.27601","title":"The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial","year":2010,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"UCB Pharma; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Placebo; Internal medicine; Randomized controlled trial; Polyarthritis; Surgery; Arthritis; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00321271,0.001367769,0.003502775,0.0004093606,0.0005719014,0.001047457,0.0008683003,0.002475949,0.004121548],"category_scores_gemma":[0.003162658,0.0006712721,0.001963749,0.0004548751,0.00101834,0.0009425612,0.0002681697,0.002288523,0.0007608116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004673766,"about_ca_system_score_gemma":0.0007819739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004158738,"about_ca_topic_score_gemma":0.0005537619,"domain_scores_codex":[0.9985978,0.0008663767,0.0001313235,0.0001856934,0.0001020423,0.0001168305],"domain_scores_gemma":[0.9978427,0.0007873832,0.0005509656,0.0001388064,0.0001642096,0.0005159955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9760156,0.004372433,0.0008943088,0.0006523875,0.0009220199,0.00004080863,0.00004544732,0.0001408532,0.002236883,0.0000294127,0.0003173068,0.01433252],"study_design_scores_gemma":[0.9484633,0.04831328,0.002144763,0.00003429868,0.0003737425,0.00003766248,0.00001015161,0.0001572875,0.0002138797,0.00003356252,0.0002106671,0.000007318605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844284,0.01016826,0.0005489568,0.0005517875,0.000421878,0.001988463,0.0005913035,0.00007781351,0.001223223],"genre_scores_gemma":[0.9901335,0.003386348,0.001049597,0.0008984039,0.0006464768,0.002376019,0.000647484,0.0000134984,0.0008486952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004121548,"threshold_uncertainty_score":0.0169906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.014021235672382,"score_gpt":0.2806700027418059,"score_spread":0.2666487670694239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}